NHS National Framework for Transition Products (Nintedanib and Dalbavancin)
Description
Project title: NHS National Framework for Transition Products (Nintedanib and Dalbavancin) commencing 1st May 2026
Offer reference number: CM/TNS/25/5736
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months.
CM/TNS/25/5736 Nintedanib and Dalbavancin
Lot 1 DLN/DNW: 01/05/2026 to 30/09/2027 (17 months)
Lot 2 DLS/DNE: 01/05/2026 to 31/05/2027 (13 months)
Lot 3 DCE/DSW: 01/05/2026 to 31/01/2027 (9 months)
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
The rest of this notice
The tender documents, the buyer's named contact, the award history and our AI analysis for this notice are part of Pro. Start a free trial to open the full record.
- Download the tender documents
- Contact the buyer directly
- See who won, and for how much
- Read the AI analysis of scope and risk
- Get alerts for tenders like this one
14 days free. No card required.
Guides for bidders
New to public sector tendering? These short guides explain how the process works.